Skip to Content

Dutasteride Pregnancy and Breastfeeding Warnings

Dutasteride is also known as: Avodart

Dutasteride Pregnancy Warnings

Use is contraindicated. AU TGA pregnancy category: X US FDA pregnancy category: X Comments: -This drug may cause fetal harm as abnormalities in the genitalia of male fetuses are an expected consequence of this drug's inhibition of the conversion of testosterone to dihydrotestosterone (DHT). -Condom use is recommended for male patients with female partners who are or may potentially be pregnant as it is not known whether a male fetus may be adversely affected if his mother is exposed to the semen of a patient being treated with this drug (the risk of which is greatest during the first 16 weeks of pregnancy). -Patients should not donate blood until at least 6 months following their last dose to prevent pregnant women from receiving this drug through blood transfusion. -The possibility of reduced male fertility cannot be excluded.

Animal studies have revealed adverse effects in male fetuses including inhibition of normal development of external genitalia and feminization of the genitalia. This drug is secreted into semen; however, the amount of this drug available for vaginal absorption may be reduced by how highly protein-bound (greater than 96%) this drug is in human semen. In a study with healthy men aged 18 to 52, reductions in sperm count, semen volume, and sperm motility were observed; however, sperm concentration and sperm morphology were unaffected. AU TGA pregnancy category X: Drugs which have such a high risk of causing permanent damage to the fetus that they should not be used in pregnancy or when there is a possibility of pregnancy. US FDA pregnancy category X: Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use of the drug in pregnant women clearly outweigh potential benefits.

See references

Dutasteride Breastfeeding Warnings

Use is contraindicated. Excreted into human milk: Unknown Excreted into animal milk: Unknown Comments: The effects in the nursing infant are unknown.

See references

References for pregnancy information

  1. "Product Information. Duagen (dutasteride)." GlaxoSmithKline Healthcare, Pittsburgh, PA.

References for breastfeeding information

  1. "Product Information. Duagen (dutasteride)." GlaxoSmithKline Healthcare, Pittsburgh, PA.

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.